These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. ENU-mutagenesis mice with a non-synonymous mutation in Grin1 exhibit abnormal anxiety-like behaviors, impaired fear memory, and decreased acoustic startle response. Umemori J; Takao K; Koshimizu H; Hattori S; Furuse T; Wakana S; Miyakawa T BMC Res Notes; 2013 May; 6():203. PubMed ID: 23688147 [TBL] [Abstract][Full Text] [Related]
25. Schizophrenia-relevant behaviours in a genetic mouse model for Y2 deficiency. Karl T; Chesworth R; Duffy L; Herzog H Behav Brain Res; 2010 Mar; 207(2):434-40. PubMed ID: 19879900 [TBL] [Abstract][Full Text] [Related]
26. Downregulation of 5-hydroxytryptamine Zhang W; Liu J; Feng J; Jia M; Zhang G; Wen X Behav Brain Res; 2018 Apr; 341():212-223. PubMed ID: 29278697 [TBL] [Abstract][Full Text] [Related]
27. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine. Nabeshima T; Mouri A; Murai R; Noda Y Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514 [TBL] [Abstract][Full Text] [Related]
28. A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice. Errico F; D'Argenio V; Sforazzini F; Iasevoli F; Squillace M; Guerri G; Napolitano F; Angrisano T; Di Maio A; Keller S; Vitucci D; Galbusera A; Chiariotti L; Bertolino A; de Bartolomeis A; Salvatore F; Gozzi A; Usiello A Transl Psychiatry; 2015 Feb; 5(2):e512. PubMed ID: 25689573 [TBL] [Abstract][Full Text] [Related]
29. Sensitivity to MK-801 in phospholipase C-β1 knockout mice reveals a specific NMDA receptor deficit. Gray L; McOmish CE; Scarr E; Dean B; Hannan AJ Int J Neuropsychopharmacol; 2009 Aug; 12(7):917-28. PubMed ID: 19236734 [TBL] [Abstract][Full Text] [Related]
31. Prolonged Ketamine Effects in Sp4 Hypomorphic Mice: Mimicking Phenotypes of Schizophrenia. Ji B; Wang X; Pinto-Duarte A; Kim M; Caldwell S; Young JW; Behrens MM; Sejnowski TJ; Geyer MA; Zhou X PLoS One; 2013; 8(6):e66327. PubMed ID: 23823008 [TBL] [Abstract][Full Text] [Related]
32. The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia. Ju P; Cui D Acta Biochim Biophys Sin (Shanghai); 2016 Mar; 48(3):209-19. PubMed ID: 26837414 [TBL] [Abstract][Full Text] [Related]
33. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine]. Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L Encephale; 2001; 27(1):53-9. PubMed ID: 11294039 [TBL] [Abstract][Full Text] [Related]
34. D-Aspartate: An endogenous NMDA receptor agonist enriched in the developing brain with potential involvement in schizophrenia. Errico F; Mothet JP; Usiello A J Pharm Biomed Anal; 2015 Dec; 116():7-17. PubMed ID: 25868730 [TBL] [Abstract][Full Text] [Related]
35. NMDA receptor-deficient mice display sexual dimorphism in the onset and severity of behavioural abnormalities. Milenkovic M; Mielnik CA; Ramsey AJ Genes Brain Behav; 2014 Nov; 13(8):850-62. PubMed ID: 25327402 [TBL] [Abstract][Full Text] [Related]